School of International Biodesign

What School of International Biodesign does

School of International Biodesign (SiB), formerly Stanford-India Biodesign, is a government-funded MedTech innovation fellowship program established in 2008 and operated under India's Department of Biotechnology, Ministry of Science and Technology. It is co-administered by AIIMS New Delhi and IIT Delhi, leveraging the clinical immersion of AIIMS and the engineering capacity of IIT Delhi to train cohorts of fellows in a structured 3i (Identification, Invention, Implementation) biodesign methodology. The program has produced seven cohorts through 2020-2021 and is currently accepting applications for the 2026 September batch, with 18 staff supporting operations.

SiB's commercial output is a portfolio of ten medical devices spanning neonatal care (Windmill/NeoBreathe foot-operated resuscitator), newborn hearing screening (Sohum, using BERA-based telemedicine-enabled diagnostics), wound healing (Innochi Care), ostomy and incontinence management (SphinX, Qora), nasal foreign body removal (NoXeno), intraosseous vascular access (Ozyn-D, CE Marked and CDSCO certified), AI-driven blood diagnostics (MorphX, using microfluidics and multispectral imaging), limb immobilization (LIMO), and orthopedic casting (FlexiOH, with 2,000+ surgeon adopters and 30,000+ units sold). Devices reach markets through direct licensing to manufacturers and distribution partners including Phoenix Medical Systems, Medline, Cardinal Health, and Owens & Minor, supplemented by SiB's own e-commerce storefront. Qora holds US FDA clearance and Sohum has undergone Indian Health Technology Assessment by the Department of Health Research, ICMR & Ministry of Health.

The organization's business model is non-commercial at the program level: it is funded by the Government of India and does not have external investors or a traditional startup capital structure. Intellectual property developed through fellowships belongs to the fellows and their formed startups, with SiB providing methodological support and ecosystem access. International collaborations with Stanford University, Hiroshima University, Queensland University of Technology, and Tottori University support fellowship exchanges and knowledge transfer, while operating geographies have expanded to include Uganda, Tanzania, Bhutan, and Guatemala in addition to the Indian base.

Name

School of International Biodesign

Legal name

School of International Biodesign

Website

https://schoolofbiodesign.in

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

11–50 employees

Short description

School of International Biodesign (SiB) is a Government of India-funded MedTech innovation fellowship, co-administered by AIIMS New Delhi and IIT Delhi, that trains fellows in the 3i biodesign methodology and has produced a portfolio of ten commercialized medical devices spanning neonatal care, diagnostics, wound healing, and orthopedics.

Ownership category

akta.pro rank

Product category

Medical Technology Innovation Training

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Surgical and Medical Instrument Manufacturing (339112)

SIC

Services-Commercial Physical & Biological Research (8731), Surgical & Medical Instruments & Apparatus (3841), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)

akta.pro secondary industries

Health & Biomedical Research Universities (Academic Medical Center–Affiliated) (EDAHABAC), Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays) (HLAAALAO)

Keywords

• Medical device innovation
• Biodesign fellowship program
• Medtech research training
• Clinical needs identification
• Healthcare technology development

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Distribution channels3 records

Marketing channels4 records

Core offering

School of International Biodesign (SiB) runs a MedTech innovation fellowship program that trains aspiring innovators through the proprietary 3i framework (Identification, Invention, Implementation), identifying unmet clinical needs at AIIMS New Delhi and developing medical device solutions with IIT Delhi engineering expertise. The program has produced 10 commercialized medical devices, spanning AI diagnostics (MorphX), BERA hearing screening, and telemedicine platforms, and licenses its developed technologies to medical device companies.

Product overview

School of International Biodesign (SiB) is a MedTech innovation fellowship program that has developed a portfolio of medical devices addressing unmet clinical needs. The product portfolio includes ten commercialized medical devices: Innochi Care (wound healing), Windmill/NeoBreathe (neonatal resuscitation), Sohum (newborn hearing screening), SphinX (ostomy management), NoXeno (nasal foreign body removal), Qora (incontinence management), Ozyn-D (intraosseous access), MorphX (AI diagnostics), LIMO (limb immobilization), and FlexiOH (orthopedic cast). These products span neonatal care, wound management, diagnostic screening, surgical/access devices, and rehabilitation, with several incorporating advanced technologies such as AI, telemedicine capabilities, and specialized materials. The program also maintains a pipeline of emerging technologies including VR rehabilitation, anesthesia devices, and fetal monitoring systems.

Differentiator

Problem solved

Functional benefit

Products and services

• SiB MedTech Innovation Fellowship Program A structured MedTech innovation fellowship program hosted at AIIMS New Delhi and IIT Delhi, training engineers, clinicians, and entrepreneurs through the 3i framework to identify unmet clinical needs and develop commercializable medical device solutions. Funded by the Department of Biotechnology, Government of India.
• MorphX (AI-driven diagnostic) An AI-driven diagnostic medical device developed by SiB fellows using the 3i framework, intended to support clinical decision-making in healthcare settings.
• BERA Hearing Screening System A BERA (Brainstem Evoked Response Audiometry) hearing screening medical device developed by SiB fellows, intended for clinical use in audiology and early hearing loss detection.

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature1 record

Recent moves6 records

Expansion highlights5 records

Direct peers

• Imperial College London Institute of Global Health Innovation: University-affiliated program developing medical technologies and training clinical-innovation fellows; comparable academic MedTech innovation function to SiB.
• Japan Biodesign: Japan's national biodesign fellowship hosted at Hiroshima University (a SiB international partner), training fellows in the same need-driven innovation methodology and creating MedTech startups in the region.
• BioInnovate Ireland: University-affiliated fellowship program following the Stanford Biodesign model, focused on identifying unmet clinical needs and developing MedTech solutions in Ireland — directly comparable structure and output to SiB.
• MIT Hacking Medicine: MIT-based initiative that runs health hackathons, fellowship-style programs, and startup support for MedTech innovation; shares SiB's fellowship-and-startup-formation orientation.
• Fogarty Institute for Innovation: Non-profit MedTech incubator that mentors clinical innovators in device development from concept through commercialization — overlapping mission of need-driven MedTech innovation and startup formation.
• CÚRAM (Science Foundation Ireland Centre for Research in Medical Devices): Ireland's national research centre for medical device innovation combining academic researchers, clinicians, and industry partners — analogous to SiB's AIIMS–IIT Delhi partnership structure.
• Johns Hopkins Center for Bioengineering Innovation and Design: University-based MedTech innovation center at Johns Hopkins that trains students and clinicians in need-driven device development and commercialization — comparable in academic-clinical collaboration model to AIIMS/IIT Delhi hosted SiB.
• Stanford Byers Center for Biodesign: The original parent program from which SiB (formerly Stanford-India Biodesign) was spun out in 2008; trains fellows in the same biodesign methodology and incubates MedTech startups, making it the closest functional peer.
• Singapore-Stanford Biodesign: Asia-Pacific sister program operating under the same Stanford Biodesign framework, training fellows in need-driven MedTech innovation and company formation — directly comparable to SiB in mission and methodology.

Emerging players

• Consure Medical: SiB-incubated startup (SphinX/Qora ostomy and stool management devices) distributed through Medline, Cardinal Health, and Owens & Minor; representative SiB portfolio company used here as a downstream comparator.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/school/biodesign.school

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about School of International Biodesign